DB Capital Partners Healthcare, L.P. c/o Robert T. Dhamer DBC I, LLC Brownsville, TX 78520 (the “Purchaser”) Re: Securities Purchase Agreement Dear Sirs and Madams:Securities Purchase Agreement • April 23rd, 2024 • Renalytix PLC • Services-medical laboratories
Reference is made to the securities purchase agreement between Renalytix plc (the “Company”) and the Purchaser dated 5 April 2024 (the “Securities Purchase Agreement”). The Purchaser has notified the Company by serving a Subsequent Tranche Notice on 18 April 2024 of their election to purchase 1,333,334 Ordinary Shares (the “Subsequent Tranche Shares”) for a total subsequent tranche purchase price of $500,000.25 (the “Notice”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Securities Purchase Agreement.
April 17, 2024 Thomas McLain Dear Tom:Separation Agreement • April 23rd, 2024 • Renalytix PLC • Services-medical laboratories
As we have discussed, your employment with Renalytix AI, Inc. (the “Company”) is coming to an end, effective as of April 30, 2024 (the “Separation Date”). The purpose of this letter agreement (this “Agreement”) is to confirm the terms concerning your transition from employment. Capitalized terms not defined in this Agreement will have the respective meanings ascribed to them in the Employment Agreement by and between you and the Company, dated as of June 1, 2019 (the “Employment Agreement”).
